Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Reverse MAPPIT detects disruptors of protein-protein interactions in human cells


Reverse mammalian protein-protein interaction trap (MAPPIT) is a mammalian reverse two-hybrid technology. The method is adapted from the forward MAPPIT technique, a two-hybrid complementation system in which the interaction between a bait-fusion protein and a prey-fusion protein restores ligand-dependent cytokine receptor signaling. In the reverse mode described in detail here, a positive readout is generated on disruption of the designated protein-protein interactions. Reverse MAPPIT functions in intact human cells, facilitating simultaneous analysis of disruption, toxicity and permeability of the tested compounds, making it particularly suitable for screening for molecules that target therapeutically interesting protein-protein interactions or for mapping the interaction interface between proteins. The total handling time of a typical reverse MAPPIT experiment is 9 h and is spread over 4–5 d.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Principles of forward and reverse MAPPIT.
Figure 2: Overview of the plasmids and the protein chimeras that they encode.


  1. 1

    Arkin, M.R. & Wells, J.A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat. Rev. Drug Discov. 3, 301–317 (2004).

    CAS  Article  PubMed  Google Scholar 

  2. 2

    Vidal, M., Braun, P., Chen, E., Boeke, J.D. & Harlow E. Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc. Natl. Acad. Sci. USA 93, 10321–10326 (1996).

    CAS  Article  PubMed  Google Scholar 

  3. 3

    Eyckerman, S. et al. Design and application of a cytokine-receptor-based interaction trap. Nat. Cell Biol. 3, 1114–1119 (2001).

    CAS  Article  PubMed  Google Scholar 

  4. 4

    Cook, W.S. & Unger, R.H. Protein tyrosine phosphatase 1B: a potential leptin resistance factor of obesity. Dev. Cell 2, 385–387 (2002).

    CAS  Article  PubMed  Google Scholar 

  5. 5

    Eyckerman, S. et al. Reverse MAPPIT: screening for protein-protein interaction modifiers in mammalian cells. Nat. Methods 2, 427–432 (2005).

    CAS  Article  PubMed  Google Scholar 

  6. 6

    Milstein, S. & Vidal, M. Perturbing interactions. Nat. Methods 2, 412–414 (2005).

    CAS  Article  PubMed  Google Scholar 

  7. 7

    Takebe, Y. et al. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the Simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell Biol. 8, 466–472 (1988).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8

    Ausubel, F.M. et al. (eds.) in Current Protocols in Molecular Biology Suppl. 56 15.1.1–15.1.14 (Wiley Publishing, Indianapolis, IN, 2005).

    Google Scholar 

  9. 9

    Eyckerman, S. et al. Design and use of a mammalian protein-protein interaction trap (MAPPIT). Sci. STKE 162, PL18 (2002).

    Google Scholar 

Download references


We thank Prof. Dr. J. Vandekerckhove for continued support and Dominiek Catteeuw and Annick Verhee for technical assistance in the development of the reverse MAPPIT method. This project was supported by grants from the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen; GBOU 010090), Ghent University (UGent; GOA 12051401) and the valorization fund of the Flanders Interuniversity Institute for Biotechnology (VIB). I.L. and S.E. are Postdoctoral Fellows of the Fund for Scientific Research–Flanders (FWO-V).

Author information



Corresponding author

Correspondence to Jan Tavernier.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lemmens, I., Lievens, S., Eyckerman, S. et al. Reverse MAPPIT detects disruptors of protein-protein interactions in human cells. Nat Protoc 1, 92–97 (2006).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing